Revance Therapeutics, Inc. 4
4 · Revance Therapeutics, Inc. · Filed Feb 29, 2016
Insider Transaction Report
Form 4
BYRNES ROBERT F
Director
Transactions
- Gift
Common Stock
2016-02-24−10,999→ 0 total - Gift
Common Stock
2016-02-24+10,999→ 13,665 total(indirect: By Trust)
Footnotes (1)
- [F1]Represents transfer of shares to the Mr. Byrnes' Family Trust. Mr. Byrnes continues to beneficially own such shares through indirect ownership through The Byrnes Family Trust.